Treatment of chronic enteric carriers of Salmonella typhosa with ampicillin.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002353:Carrier State / Q000150:complications / Q000188:drug therapy*; D005243:Feces / Q000382:microbiology; D005260:Female; D005705:Gallbladder Diseases; D006801:Humans; D008297:Male; D008875:Middle Aged; D011339:Probenecid / Q000008:administration & dosage / Q000627:therapeutic use; D012485:Salmonella typhi / Q000187:drug effects / Q000302:isolation & purification; D012871:Skin Diseases / Q000139:chemically induced; D013997:Time Factors; D014435:Typhoid Fever / Q000150:complications / Q000188:drug therapy*
D000667:Ampicillin; D011339:Probenecid